Oncology Institute (TOI) Stock Statistics & Valuation Metrics

Oncology Institute has a market cap or net worth of $308.38M. The enterprise value is $301.10M.

Oncology Institute has 98,839,140 shares outstanding. The number of shares has decreased by -2.65% in one year.

Oncology Institute’s return on equity (ROE) is 3.86 and return on invested capital (ROIC) is -35.70%.

The current PE Ratio of Oncology Institute is ―. Oncology Institute’s PEG ratio is 2.27.

In the last 12 months, Oncology Institute had revenue of 502.73M and earned -60.61M in profits. Earnings per share was -0.54.

In the last 12 months, operating cash flow was -24.59M and capital expenditures -3.20M, giving a free cash flow of -27.79M billion.

Oncology Institute pays an annual dividend of ―, resulting in a dividend yield of ―

Oncology Institute upcoming earnings date is May 13, 2026, After Close (Confirmed).

Oncology Institute as a current ratio of 1.59, with Debt / Equity ratio of -167.22%

In the past 12 months, Oncology Institute has paid -131.00K in taxes.

Oncology Institute EV to EBITDA ratio is -115.28, with an EV/FCF ratio of -120.89.

Oncology Institute has $33.56M in cash and marketable securities with $26.29M in debt, giving a net cash position of $7.28M billion.

Gross margin is 13.82%, with operating margin of -7.18%, and net profit margin of -12.06%.

The average price target for Oncology Institute is $7.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy